FDA Approval Status for CJC-1295 As of 2026, CJC-1295 has no FDA-approved indications [fda.gov]
To understand it fully, we need to quickly cover an entirely new hormone that we have yet to discuss called ghrelin
Sermorelin is a synthetic fragment of growth hormonereleasing hormone (GHRH) that signals the pituitary to release GH in pulses
Mechanism of Action Stimulates angiogenesis (formation of new blood vessels) Increases fibroblast activity and collagen synthesis Reduces pro-inflammatory cytokines and promotes anti-inflammatory cascades Enhances tendon-to-bone healing , muscle fiber regeneration, and gut lining repair Works through interaction with the nitric oxide system , aiding circulation and tissue oxygenation BPC157 promotes tendon and ligament healing, accelerates wound closure, and stabilizes vascular response after injury. Sikiric et al., Current Pharmaceutical Design Applications Joint pain, tendonitis, ligament tears Ulcers, IBS, leaky gut Muscle strain, post-surgical recovery Neural repair and recovery from nerve compression Post-cycle inflammation and tissue stress Delivery Administered via subcutaneous injection , near site of injury or systemically Can also be taken orally for GI-related issues (due to gastric stability) MK677 (Ibutamoren) Overview and How It Works MK677 (Ibutamoren) is an orally active growth hormone secretagogue that mimics the action of ghrelin to stimulate the release of growth hormone (GH) and IGF1
IGF1 elevation: Sustained administration can significantly increase IGF1 levels [5]
